Treatment of dermatitis with dehydroepiandrosterone-glucocorticoid combinations
AssigneeRxDino, LLC
InventorThomas Geracioti
Life of this patent
Estimating the term…
Abstract
Dermatitis can be effectively treated with the combined administration of dehydroepiandrosterone (DHEA) and a glucocorticoid. Systemic, topical and prepackaged DHEA-glucocorticoid embodiments are described.
Claims24
A method of treating dermatitis in a mammal by administering to said mammal an effective dose of a combination of dehydroepiandrosterone (DHEA), or DHEA derivatives, and a glucocorticoid.
A dose pack comprising sufficient DHEA oral unit doses and sufficient glucocorticoid oral unit doses for about three to about fourteen days of administration, packaged together with instructions for administration.
A topical pharmaceutical composition for the treatment of dermatitis comprising a safe and effective amount of DHEA, a safe and effective amount of a glucocorticoid, and a pharmaceutically acceptable topical carrier or vehicle.
Dependencies are inferred from the claim text.